Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

European biotech – surviving the storm

October 22, 2003 Research and Development Europe, biotech, investment

Flexibility and constant adjustment are necessary to survive one of the toughest times in the history of the industry.There have …
Feature

A smoother ride to market

October 22, 2003 Research and Development clinical development, patient recruitment

The concepts of the 'business case' and 'performance management' have become popular even outside business circles, but clinical trials for …
Feature

Don’t lose your head

October 21, 2003 Research and Development industry reputation

Feature

Commercial and R&D: reinventing the relationship

October 17, 2003 Research and Development R&D, commercial

Traditionally, pharma companies have been run as research-based organisations relying on well-integrated internal R&D capabilities to feed their commercial pipelines …
Feature

R&D competitive intelligence

October 17, 2003 Research and Development competitive intelligence

Feature

Managing alliances for performance

October 16, 2003 Research and Development alliance

These days no pharmaceutical company would be caught admitting that they did not have an alliance strategy. After all, the …
Feature

From lab to limousine

October 16, 2003 Research and Development biotech, start-up

Attend any networking conference bringing together fledgling biotechnology companies and investors, whether financial or industry, and you will repeatedly hear …
Feature

Emotional relationships: marriage vs. holiday romances

October 15, 2003 Research and Development CRO, contract research, contract research organisation

If you were to ask leading CRO executives they would tell you that blue chip pharma companies outsource their critical …
Feature

Technology in clinical trials

October 15, 2003 Research and Development clincial testing, technology

The major drive for the pharma industry is the pressure to reduce drug development times and costs. Although paper-based processes …
Feature

Waiting for the upturn

October 15, 2003 Research and Development drug development, pipelines

Estimates vary considerably, but many analysts put the current cost of bringing a drug to market at around $800 million, …
Feature

Project management – you get what you pay for

October 15, 2003 Research and Development project management

Pharma projects have project managers. Technology projects have project managers. But there is a world of difference between them. That …
Feature

Powering up the pipeline

October 14, 2003 Research and Development blockbusters, drug development, pipelines

Feature

The European private pharma sector

October 14, 2003 Research and Development pharma, private

Feature

The biotech sector’s growth-innovation paradox

October 9, 2003 Research and Development biotech, innovation

The biotech sector is facing a paradox. Traditionally, the strength of the sector has been based on the ability of …
Feature

The pharmaceutical doll’s house

October 9, 2003 Research and Development biotech

The turn of the century has witnessed a period of intense uncertainty and instability within the pharma sector. After decades …
Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025